A Phase I, Open-Label, Randomized Crossover Trial to Investigate the Pharmacokinetic Interaction Between Steady-State Lopinavir/Ritonavir and Single-Dose TMC207 in Healthy Volunteers.

Trial Profile

A Phase I, Open-Label, Randomized Crossover Trial to Investigate the Pharmacokinetic Interaction Between Steady-State Lopinavir/Ritonavir and Single-Dose TMC207 in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2014

At a glance

  • Drugs Bedaquiline; Lopinavir/ritonavir
  • Indications HIV infections; Tuberculosis
  • Focus Pharmacokinetics
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 15 Jul 2009 Actual end date (1 May 2009) added as reported by ClinicalTrials.gov.
    • 15 Jul 2009 Actual end date (1 May 2009) added as reported by ClinicalTrials.gov.
    • 15 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top